Capital and Issued Shares
|
Capital |
Issued shares |
April 1, 2021 |
¥1,197.9 million |
30,563,199 shares |
March 31, 2022 |
¥1,197.9 million |
30,563,199 shares |
March 31, 2023 |
¥1,197.9 million |
30,563,199 shares |
March 31, 2024 |
¥1,197.9 million |
30,563,199 shares |
Notes: In April 2021, through a sole-share transfer, the Company was established as the wholly owned parent company of ASKA Pharmaceutical Co. Ltd.